早期NSCLC立体定向消融放疗后局部区域复发的挽救治疗
国际肺癌研究协会先进放射技术委员会撰文,针对早期非小细胞肺癌接受立体定向消融放疗(SABR)后出现的孤立局部复发(LR)和区域复发(RR),讨论诊断检查、挽救治疗后的临床结局与复发模式及管理选择。主要结论为充分挽救的LR生存与无复发原发SABR后相似,挽救的RR生存与新生III期患者相似。
要点
- 充分挽救的LR生存与无复发原发SABR后相似。
- 挽救的RR生存与新生III期患者相似。
- 过半挽救患者无第二复发,但第二失败以远处为主,尤其RR。
核心结论
- 充分挽救的LR患者生存与无复发原发SABR后相似。
- 挽救的RR患者生存与新生III期患者相似,不论淋巴结负荷或位置。
- 过半挽救患者未出现第二复发,但第二失败以远处为主,尤其RR。
研究设计与样本
- 国际肺癌研究协会先进放射技术委员会撰写的综述性文章,讨论SABR后LR和RR的管理。
主要发现
- 孤立LR和RR仅占SABR后复发少数,但随SABR应用扩大其管理日益重要。
- 充分挽救的LR生存与无复发原发SABR后相似。
- 挽救的RR生存与新生III期患者相似,不论淋巴结负荷或位置。
- 过半挽救患者无第二复发,但第二失败以远处为主,尤其RR。
关键数值与推荐
- 孤立LR可采取切除加淋巴结清扫、重复SABR、热消融或全身治疗。
- RR可采取联合放化疗、单纯放疗或化疗,或支持治疗。
- 推荐SABR后挽救治疗后进行定期结构化随访。
临床怎么用
- 管理需严格的多学科协调。
- 孤立LR可选切除加淋巴结清扫、重复SABR、热消融或全身治疗。
- RR可选联合放化疗、单纯放疗或化疗,或支持治疗。
- SABR后挽救治疗后推荐定期结构化随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although isolated local (LRs) and regional recurrences (RRs) constitute a minority of post-stereotactic ablative radiotherapy (SABR) relapses, their management is becoming increasingly important as the use of SABR continues to expand. However, few evidence-based strategies are available to guide treatment of these potentially curable recurrences. On behalf of the Advanced Radiation Technology Committee of the International Association for the Study of Lung Cancer, this article was written to address management of recurrent disease. Topics discussed include diagnosis and workup, including the roles of volumetric and functional imaging as well as histopathologic methods; clinical outcomes after salvage therapy; patterns of recurrence after salvage therapy; and management options. Our main conclusions are that survival for patients with adequately salvaged LRs is similar to that for patients after primary SABR without recurrence, and survival for those with salvaged RRs (regardless of nodal burden or location) is similar to that of patients with de novo stage III disease. Although more than half of patients who undergo salvage do not develop a second relapse, the predominant pattern of second failure is distant, especially for RRs. Management requires rigorous multidisciplinary coordination. Isolated LRs can be managed with resection and nodal dissection, repeat SABR, thermal ablation, or systemic therapies. RRs can be treated with combined chemoradiotherapy, radiation or chemotherapy alone, or supportive services. Finally, regular and structured follow-up is recommended after post-SABR salvage therapy.
引用
- Brooks ED, Verma V, Senan S, et al. Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC. J Thorac Oncol. 2019. PMID: 31712134. doi:10.1016/j.jtho.2019.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。